Psychedelic drugs to treat depression
Researchers are exploring the science of psychedelic drugs as a potential treatment for depression. How effective could they be, and what are the regulatory and legal challenges in their use?

Human germline genome editing (363 KB , PDF)
Changes made to DNA in human eggs, sperm or embryos (germline cells) can be passed on to future generation. The methods used to to make such changes are referred to as human germline genome editing (hGGE). This POSTnote reviews techniques available for hGGE, their safety and potential applications. It also outlines current regulation and governance of hGGE and examines issues raised by any potential future uses of hGGE.
Key Points:
UK law prohibits the use of hGGE as part of IVF treatment in women.
POSTnotes are based on literature reviews and interviews with a range of stakeholders, and are externally peer reviewed. POST would like to thank interviewees and peer reviewers* for kindly giving up their time during the preparation of this briefing, including:
Human germline genome editing (363 KB , PDF)
Researchers are exploring the science of psychedelic drugs as a potential treatment for depression. How effective could they be, and what are the regulatory and legal challenges in their use?
This briefing outlines what is known about the factors that shape gender incongruence and gender dysphoria. The impact on the NHS from increased referrals for gender identity care is discussed.
This POSTnote summarises child food insecurity and Free School Meal initiatives in England, highlighting relevant research evidence and stakeholder perspectives.